Lorenzo Briganti
@lorenzobriganti.bsky.social
PhD in Applied Physics, working with structural biology, biophysics and biochemistry of retroviruses. Passionate about science in general, my family and life.
Proud to share our first work in 2025, where we showed another mechanism for HIV-1 inhibition by Lenacapavir
journals.plos.org/plospathogen...
journals.plos.org/plospathogen...
The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavir
Author summary Lenacapavir (LEN) is used to treat adults with multi-drug-resistant HIV-1 infection. LEN is the first in class, highly potent and long-acting antiretroviral, which works by a unique mec...
journals.plos.org
January 31, 2025 at 6:08 PM
Proud to share our first work in 2025, where we showed another mechanism for HIV-1 inhibition by Lenacapavir
journals.plos.org/plospathogen...
journals.plos.org/plospathogen...